The notion of a significantly deregulated NOTCH1 pathway was later confirmed by the Dalla-Favera group to include CLL cells beyond genetic mutations, i.e., affecting also “bona fide” NOTCH1-wild type CLL cases. The gene discussed is NOTCH1; the disease is B-cell chronic lymphocytic leukemia.